Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 389,130 | 290,515 | 50,699 | 0 | 0 |
| Cost of Goods | 23,049 | 20,061 | 3,094 | N/A | N/A |
| Gross Profit | 366,081 | 270,454 | 47,605 | N/A | N/A |
| Operating Expenses | 204,835 | 204,767 | 157,316 | 145,196 | 68,275 |
| Operating Income | 161,295 | 65,748 | -109,617 | -145,196 | -68,275 |
| Interest Expense | 0 | 0 | 0 | 0 | 1,492 |
| Other Income | 28,176 | 29,608 | 122,514 | 5,221 | 197 |
| Pre-tax Income | 189,471 | 95,356 | 12,897 | -139,975 | -69,570 |
| Income Tax | -15,360 | 6,197 | 1,965 | N/A | N/A |
| Net Income Continuous | 204,831 | 89,159 | 10,932 | -139,975 | -69,570 |
| Net Income | $204,831 | $89,159 | $10,932 | $-139,975 | $-69,570 |
| EPS Basic Total Ops | 7.08 | 3.12 | 0.40 | -5.49 | -3.13 |
| EPS Basic Continuous Ops | 7.08 | 3.12 | 0.40 | -5.49 | -3.13 |
| EPS Diluted Total Ops | 6.84 | 3.00 | 0.39 | -5.49 | -3.13 |
| EPS Diluted Continuous Ops | 6.84 | 3.00 | 0.39 | -5.49 | -3.13 |
| EPS Diluted Before Non-Recurring Items | N/A | 4.26 | -2.76 | -4.51 | -3.13 |
| EBITDA(a) | $167,846 | $72,462 | $-103,706 | $-141,811 | $-65,506 |